Natco Pharma Ltd
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 |
|---|---|---|---|
| Revenue | 644.90 | 681.70 | 584.10 |
| Operating Expense | 490.60 | 516.40 | 408.50 |
| Net Profit | 74.60 | 209.60 | 106.90 |
| Net Profit Margin | 11.57% | 30.75% | 18.30% |
| Earning Per Share | 4.17 | 11.70 | 5.97 |
| EBIDTA | 137.90 | 270.50 | 183.50 |
| Effective Tax Rate | 7.13% | 3.39% | 14.92% |
Particulars
Jun 2026
Revenue644.90
Operating Expense490.60
Net Profit74.60
Net Profit Margin11.57
Earning Per Share4.17
EBIDTA137.90
Effective Tax Rate7.13
